EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma
Clinical trial NCT04509726 · COMPLETED
Trial details
- NCT number
- NCT04509726
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2026-01-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.